Vivani Medical, Inc. (VANI) stock
VANINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$1.05+0.00 (0.00%)
Close on Nov 18, 2026Market cap $94.71MP/E –Yield –
Vivani Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Vivani Medical's operating income for the twelve months ending Jun 30, 2026 was -$27.23M. For fiscal 2025 it was -$27.56M. The highest annual figure on record is -$13.32M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$27.56M | – |
| FY2024 | Dec 31, 2024 | -$24.68M | – |
| FY2023 | Dec 31, 2023 | -$26.97M | – |
| FY2022 | Dec 31, 2022 | -$21.24M | – |
| FY2021 | Dec 31, 2021 | -$13.32M | – |
| FY2020 | Dec 31, 2020 | -$14.90M | – |
| FY2019 | Dec 31, 2019 | -$33.95M | – |
| FY2018 | Dec 31, 2018 | -$35.18M | – |
| FY2017 | Dec 31, 2017 | -$28.61M | – |
| FY2016 | Dec 31, 2016 | -$33.21M | – |
| FY2015 | Dec 31, 2015 | -$20.05M | – |
| FY2014 | Dec 31, 2014 | -$21.23M | – |
| FY2013 | Dec 31, 2013 | -$18.00M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.87M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.82M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.81M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.73M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.46M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.56M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.46M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.31M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.68M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.23M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.22M | – |
| Q3 FY2023 | Sep 30, 2023 | -$7.14M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.00M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.60M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.79M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.44M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.09M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.91M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.29M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.49M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.30M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.84M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.27M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.60M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.12M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.90M | – |
| Q4 FY2019 | Dec 31, 2019 | -$8.13M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.62M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.44M | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.77M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.88M | – |
| Q3 FY2018 | Sep 30, 2018 | -$8.55M | – |
| Q2 FY2018 | Jun 30, 2018 | -$7.99M | – |
| Q1 FY2018 | Mar 31, 2018 | -$9.77M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.43M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.75M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.87M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.56M | – |
| Q4 FY2016 | Dec 31, 2016 | -$10.38M | – |
| Q3 FY2016 | Sep 30, 2016 | -$8.50M | – |
See a number that looks wrong?